These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 36960048)
21. The crossroads: divergent roles of virus-specific CD4 van Bockel D; Kelleher A Immunol Cell Biol; 2023 Jul; 101(6):525-534. PubMed ID: 37159056 [TBL] [Abstract][Full Text] [Related]
22. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV). Poljak M; Šterbenc A; Lunar MM Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811 [TBL] [Abstract][Full Text] [Related]
23. Warts and all: Fingolimod and unusual HPV-associated lesions. Triplett J; Kermode AG; Corbett A; Reddel SW Mult Scler; 2019 Oct; 25(11):1547-1550. PubMed ID: 30427266 [TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus: often harmless but in some cases carcinogenic. Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425 [TBL] [Abstract][Full Text] [Related]
25. Multiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection: A case report. Clemente N; Alessandrini L; Vaccher E; De Paoli A; Buttignol M; Canzonieri V; Sopracordevole F Medicine (Baltimore); 2017 Jan; 96(4):e5948. PubMed ID: 28121939 [TBL] [Abstract][Full Text] [Related]
26. Anal neoplasia in persons with HIV infection. Northfelt DW AIDS Clin Care; 1996 Aug; 8(8):63-6. PubMed ID: 11363714 [TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus-related disease in men: not just a women's issue. Palefsky JM J Adolesc Health; 2010 Apr; 46(4 Suppl):S12-9. PubMed ID: 20307839 [TBL] [Abstract][Full Text] [Related]
28. [New therapeutic strategies for human papillomavirus related anogenital lesions in HIV patients: highly active antiretroviral therapy and HPV vaccines]. Fusté P; Santamaría X; Carreras R Med Clin (Barc); 2008 Jun; 131(1):30-4. PubMed ID: 18582422 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review. Stier EA; Sebring MC; Mendez AE; Ba FS; Trimble DD; Chiao EY Am J Obstet Gynecol; 2015 Sep; 213(3):278-309. PubMed ID: 25797230 [TBL] [Abstract][Full Text] [Related]
30. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549 [TBL] [Abstract][Full Text] [Related]
31. Human Immunodeficiency Virus Infection Promotes Human Papillomavirus-Mediated Anal Squamous Carcinogenesis: An Immunologic and Pathobiologic Review. Bushara O; Krogh K; Weinberg SE; Finkelman BS; Sun L; Liao J; Yang GY Pathobiology; 2022; 89(1):1-12. PubMed ID: 34535611 [TBL] [Abstract][Full Text] [Related]
32. Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies. Wei F; Xia N; Ocampo R; Goodman MT; Hessol NA; Grinsztejn B; Ortiz AP; Zhao F; Kojic EM; Kaul R; Heard I; Morhason-Bello IO; Moscicki AB; de Pokomandy A; Palefsky JM; Rodrigues LLS; Dube Mandishora RS; Ramautarsing RA; Franceschi S; Godbole SV; Tso FK; Menezes LJ; Lin C; Clifford GM J Infect Dis; 2023 Feb; 227(4):488-497. PubMed ID: 35325151 [TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus, human immunodeficiency virus and immunosuppression. Denny LA; Franceschi S; de Sanjosé S; Heard I; Moscicki AB; Palefsky J Vaccine; 2012 Nov; 30 Suppl 5():F168-74. PubMed ID: 23199960 [TBL] [Abstract][Full Text] [Related]
34. Presence of high-risk human papillomavirus genotype and human immunodeficiency virus DNA in anal high-grade and low-grade squamous intraepithelial lesions. Shiramizu B; Liang CY; Agsalda-Garcia M; Nagata I; Milne C; Zhu X; Killeen J; Berry JM; Goodman MT AIDS Res Hum Retroviruses; 2013 Jan; 29(1):178-81. PubMed ID: 22816619 [TBL] [Abstract][Full Text] [Related]
35. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. Critchlow CW; Surawicz CM; Holmes KK; Kuypers J; Daling JR; Hawes SE; Goldbaum GM; Sayer J; Hurt C; Dunphy C AIDS; 1995 Nov; 9(11):1255-62. PubMed ID: 8561979 [TBL] [Abstract][Full Text] [Related]
36. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820 [TBL] [Abstract][Full Text] [Related]
37. HPV-Associated Anal Cancer in the HIV/AIDS Patient. Wang CJ; Palefsky JM Cancer Treat Res; 2019; 177():183-209. PubMed ID: 30523625 [TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus infection and disease in HIV-infected individuals. Hagensee ME; Cameron JE; Leigh JE; Clark RA Am J Med Sci; 2004 Jul; 328(1):57-63. PubMed ID: 15254442 [TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature. Bacik LC; Chung C Int J Dermatol; 2018 Jun; 57(6):627-634. PubMed ID: 29152727 [TBL] [Abstract][Full Text] [Related]
40. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]